retatrutide weight loss results clinical trial trials BEYOND OZEMPIC: ELI LILLY for Eli Lilly's retatrutide show adults losing up to 30 percent of retatrutide weight loss results clinical

Gastric Emptying Delay: By slowing the rate at which your stomach empties food into the small intestine, GLP-1 extends the window of nutrient absorption and prolongs satiety signals

Muscle tissue has higher blood flow than subcutaneous fat, which means the medication absorbs faster and may produce a higher, shorter peak

Share this information with your healthcare team to inform treatment optimisation

This explains why weight loss with retatrutide dose escalation to 12mg exceeds what appetite suppression alone can account for

Your provider must assess for contraindications (medullary thyroid cancer history, severe retinopathy) and oversee dose escalation